| 1 |
2024 |
Paula Gonzalez‐Seligra, Lucía M. Quintero‐Borregales, Laura Ribba, Lucía Famá, Silvia Goyanes. 2024; 229.
https://doi.org/10.1002/9783527837021.ch9 |
| 2 |
2022 |
Anissa Pisani, Roberto Donno, Giulio Valenti, Pier Pompa, Nicola Tirelli, Giuseppe Bardi. Chemokine-Decorated Nanoparticles Target Specific Subpopulations of Primary Blood Mononuclear Leukocytes, Nanomaterials. 2022; 12: 3560.
https://doi.org/10.3390/nano12203560 |
| 3 |
2022 |
Sonia Panico, Sara Capolla, Sara Bozzer, Giuseppe Toffoli, Michele Dal Bo, Paolo Macor. Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System, Pharmaceutics. 2022; 14: 2605.
https://doi.org/10.3390/pharmaceutics14122605 |
| 4 |
2022 |
Rebecca D. Bierman‐Duquette, Gevick Safarians, Joyce Huang, Bushra Rajput, Jessica Y. Chen, Ze Zhong Wang, Stephanie K. Seidlits. Engineering Tissues of the Central Nervous System: Interfacing Conductive Biomaterials with Neural Stem/Progenitor Cells, Advanced Healthcare Materials. 2022; 11: 2101577.
https://doi.org/10.1002/adhm.202101577 |
| 5 |
2022 |
Giuseppe Bardi, Chemokines and nanomaterials: interaction for useful immune-applications, Exploration of Immunology. 2022; 637.
https://doi.org/10.37349/ei.2022.00073 |
| 6 |
2024 |
Giuseppe Bardi, Challenges in the Therapeutic Exploitation of Chemokine Receptor-Mediated Internalization of Nanocarriers, Frontiers in Bioscience-Landmark. 2024; 29: 350.
https://doi.org/10.31083/j.fbl2910350 |
| 7 |
2022 |
Giuseppe Bardi, Monica Neagu. Moving Forward in Nano-Immune Interactions, Nanomaterials. 2022; 12: 2033.
https://doi.org/10.3390/nano12122033 |
